Nelipepimut-S Plus GM-CSF Vaccine
Semantic Scholar uses AI to extract papers important to this topic.
E75 (nelipepimut-S) is an immunogenic peptide derived from the HER2 protein. When combined with the immunoadjuvant granulocyte… (More)
e274 Background: According to the NCI Office of Cancer Survivorship, in 2014, it is estimated there are 14.5 million cancer… (More)
E75 (nelipepimut-S) is a human leukocyte antigen (HLA)-A2/A3-restricted immunogenic peptide derived from the HER2… (More)
- Nature Reviews Clinical Oncology
Breast cancer is the most common malignancy in women and even after curative treatment, approximately 10–20% of breast cancer… (More)
Nelipepimut-S (formerly known as E75) is an immunogenic peptide from the HER2 protein that is highly expressed in breast cancer… (More)